QPID

About QPID

QPID Health operates as a clinical insights software provider, spun out from Partners HealthCare in late 2012. The company was founded by Michael Zalis and Mitchell Harris in 2011, with Michael J. Doyle later joining as President and CEO in 2012. Doyle, a seasoned executive with a background in healthcare technology and a BS in Biology from Tufts University and an MBA from the University of Chicago, was instrumental in establishing QPID as a commercial entity. The company's creation was a direct response to the challenge faced by clinicians at Massachusetts General Hospital: an overwhelming amount of patient data within electronic health records (EHRs) that was difficult to navigate to find relevant information.

QPID Health targets hospitals and integrated health systems, providing them with a platform that sits on top of their existing EHR systems. The firm's business model is centered on providing its clinical reasoning platform and a suite of applications, including the notable Q-Guide, through a software-as-a-service (SaaS) model, which can be hosted in the cloud or on-premise. Revenue is also generated through annual subscriptions for specific content, such as its 'Grouper' solution for Epic EMR customers. The company's value proposition is to enhance clinician productivity and improve patient care by reducing the time it takes to access and analyze patient information, thereby supporting better-informed clinical decisions.

The core of QPID Health's offering is its clinical intelligence platform, which leverages a powerful combination of natural language processing (NLP), clinical logic, and machine learning. This technology enables the extraction and analysis of pertinent patient facts from both structured data fields and unstructured narrative notes within the longitudinal health record—a significant feat given that up to 80% of crucial information can be buried in free-text notes. A key application, Q-Guide, provides procedure decision support by combining a patient's clinical data with established guidelines and personalized risk models. This is particularly applied to high-cost, resource-intensive procedures in areas like cardiac, vascular, and orthopedic surgery, aiming to ensure procedural appropriateness and reduce costs. In February 2016, QPID Health was acquired by eviCore healthcare, a medical benefits management company, a move intended to accelerate the support for value-based care delivery by integrating QPID's clinical insights with eviCore's care pathways.